Investigating how IRS2 affects cell division in breast cancer
IRS2 and mitotic regulation in breast cancer
This study is looking at how a protein called IRS2 affects cell division in triple negative breast cancer, with the hope of finding new ways to treat this aggressive type of cancer and improve options for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10996593 on NIH RePORTER |
What this research studies
This research aims to understand the role of Insulin Receptor Substrate 2 (IRS2) in regulating the spindle assembly checkpoint, which is crucial for proper cell division. By focusing on triple negative breast cancer (TNBC), the study will explore how IRS2 contributes to the aggressive nature of this cancer subtype. The researchers will investigate the mechanisms by which IRS2 influences cancer cell growth and survival, potentially leading to new therapeutic strategies. Patients may benefit from insights gained about targeting IRS2 for improved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with triple negative breast cancer who may benefit from novel therapeutic approaches.
Not a fit: Patients with other types of breast cancer or those not diagnosed with breast cancer may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies specifically targeting IRS2, improving outcomes for patients with triple negative breast cancer.
How similar studies have performed: While the specific targeting of IRS2 in TNBC is a novel approach, similar research has shown promise in understanding the role of signaling pathways in cancer progression.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Shaw, Leslie M — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Shaw, Leslie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.